Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon(R) for Chronic H... ( Albuferon 1200-mcg Every Two Weeks (A...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon(R) for Chronic Hepatitis C

Date:11/5/2007

Albuferon 1200-mcg Every Two Weeks (Albuferon 1200 Q2w)

-- ITT analysis shows that 55.5% of patients in the Albuferon 1200 Q2w

treatment group achieved SVR, vs. 57.9% for peginterferon alfa-2a

administered every week.

-- In heavier patients (75 kg or heavier) who were treatment-adherent,

67.9% of those in the Albuferon 1200 Q2w treatment group achieved SVR,

versus 53.3% for peginterferon alfa-2a every week.

-- Among all treatment-adherent patients in the Albuferon 1200 Q2w

treatment group, 70.6% achieved SVR, versus 66.7% for peginterferon

alfa-2a.

-- ITT analysis shows that the Albuferon 1200 Q2w treatment group

exhibited a robust early antiviral response (reduction in hepatitis C

RNA viral load to below the level of quantitation): 74.5% for

Albuferon 1200 Q2w at Week 12, vs. 65.8% for peginterferon alfa-2a.

The Albuferon 1200 Q2w treatment group also had the most rapid time to

HCV RNA negativity.

-- The rate of discontinuations due to adverse events was 18.2% in the

Albuferon 1200 Q2w treatment group, vs. 6.1% in the peginterferon alfa-

2a group. Adverse events observed were those typically expected with

interferon therapy. Dose reductions were attempted in only 24.4% of

Albuferon subjects prior to discontinuation, versus 42.9% for

peginterferon alfa-2a. Adverse events observed were those typically

expected with interferon therapy.

"In the Albuferon Phase 3 trials, we are strongly encouraging titration of dose where necessary to increase tolerability, reduce the rate of discontinuations, and maximize the therapeutic benefit of the robust early antiviral response offered by the 1200-microgram dose on a two-week administration schedule," said Dr. Stump.

Albuferon 1200-mcg Monthly (Albuferon 1200 Q4w)

-- ITT analysis shows that 50.9% of patients in the Albuferon
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8
Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials

Post Your Comments:

(Date:12/15/2009)... Reportlinker.com announces that a new market research ... Boehringer Ingelheim GmbH: PharmaVitae Profile ... ,, This analysis examines the historical ... the Rx pharmaceutical sector. The profile encompasses ... assessment of financial performance, with 1-6 year ...

(Date:12/15/2009)... Dec. 15 Waters ... that SDMS Vision Publisher(TM) (v.7.1 SR4), an electronic ... Management System (SDMS), a secure electronic repository that ... to a centralized database and is used to ... certified compliant with the SAFE-BioPharma digital identity and ...

(Date:12/15/2009)... Reportlinker.com announces that a ... in its catalogue: ,, The ... Forecasts to 2015, Competitive Benchmarking, Product ... http://www.reportlinker.com/p0168102/The-Future-of-HIV-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ,, Summary ... its latest research "The Future of ...

[0] Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile [0] Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard [0] Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis

... SAN DIEGO, Dec. 3 Biocept, an emerging ... the University of,Texas M.D. Anderson Cancer Center to ... in blood. The study will use Biocept,s,proprietary CEE(TM) ... cells from a larger heterogeneous cell population. The,focus ...

... Inc.,(Nasdaq: NUVO ) today announced that it will ... the Phase 3 SONOMA-2 (Speedy Opening of,Non-functional and Occluded ... upcoming American Society of Hematology,(ASH) 49th Annual Meeting. The ... p.m. Eastern Time (1:30 p.m. Pacific Time)., To ...

Other Medicine Technology:Biocept Announces Study to Isolate Circulating Tumor Cells from Blood 2 Nuvelo Announces Alfimeprase SONOMA-2 Catheter Occlusion Data Presentation Webcast and Conference Call 2

Biocept Announces Study to Isolate Circulating Tumor Cells from Blood Nuvelo Announces Alfimeprase SONOMA-2 Catheter Occlusion Data Presentation Webcast and Conference Call

(Date:12/15/2009)... Continuing Strike Force Operations Lead to Indictment of ... with more than $61 Million in Fraudulent Billing ... Thirty people have been charged in ... to submit more than $61 million in false ... of the Medicare Fraud Strike Force, Department of ...

(Date:12/15/2009)... decade, the United Nations Foundation has led the fight ... World Malaria Report 2009 that the global strategies for ending malaria ... Health for the United Nations Foundation , ... Washington, ... United Nations Foundation has led the fight against malaria, ...

(Date:12/15/2009)... for the unemployed or those needing additional income... known as one ... , ... Orlando, FL (PRWEB) December 15, 2009 -- RPS ... holiday cheer and good will that is going to stick around ... for out of work Americans to get back to the grind ...

(Date:12/15/2009)... with fewer complications, analysis finds, , , TUESDAY, Dec. 15 ... cancer, women and their doctors have some options, but ... biopsy" procedure is nearly as effective in diagnosing breast ... complications than the surgical version. , The new analysis, ... Annals of Internal Medicine , looked over data ...

(Date:12/15/2009)... and acquisitions are commonplace today. As competitors come ... a product portfolio they also must face integration ... A new free, white paper from Howard Leight ... Program: US Airways ," details how the merger ... newly formed company to enhance its occupational Hearing ...

Breaking Medicine News(10 mins):Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 2 Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 3 Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 4 Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 5 Health News:Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation, on Progress Shown in World Malaria Report 2009 2 Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 2 Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 3 Health News:Needle Biopsy Works Well in Diagnosing Breast Cancer 2 Health News:New White Paper Details Best Practices of an Occupational Hearing Conservation Program: US Airways 2 Health News:New White Paper Details Best Practices of an Occupational Hearing Conservation Program: US Airways 3 Health News:New White Paper Details Best Practices of an Occupational Hearing Conservation Program: US Airways 4

[1] Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La.[0] Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation, on Progress Shown in World Malaria Report 2009 [0] RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away [0] Needle Biopsy Works Well in Diagnosing Breast Cancer [0] New White Paper Details Best Practices of an Occupational Hearing Conservation Program: US Airways

... The water officials detected prescription drugs in the filtered ... raised doubts about the dangerous effects this water might ... minimal drugs such as antibiotics, antipsychotics, birth-control hormones, Viagra ... drugs end up in the wastewater is because people ...

... An exhaustive genetic study conducted on more than 3000 people ... earwax. // It could eventually explain why some people have ... ,The study has further established that people from ... and wet earwax while those with an east-Asian origin have ...

... Hospital, a major health care facility located at New ... This move is anticipated to overcome some problems associated ... was held in Bega hospital recently to examine the ... roof and frequent air conditioning failures have forced the ...

... (NUGA) meeting was the study that risk of having ... if the symptoms appeared after first delivery or during ... of Obstetrics and Gynaecology, University of Copenhagen, “It is ... risk of SUI symptoms. However, the long-term effects are ...

... The world's largest drug maker, Pfizer has announced that it ... Exubera received regulatory approvals from the US Food and Drug ... drug has been developed in collaboration with Sanofi-Aventis and Nektar ... insulin in that no needles or pens or syringes are ...

... cancer symptoms usually go undetected during the early stages, ... some the initial symptoms of the condition, according to ... The other symptoms are the clubbed finger, swollen fingertips, ... endoscopic examination of the lungs or an analysis of ...

Other Medicine News:Health News:Medications Detected In Recycled Water In Los Angeles 2 Health News:Dry Earwax Mystery Solved: Ear Wax Gene Identified 2 Health News:More prone to SUI if symptoms appear after first pregnancy and delivery 2

Medications Detected In Recycled Water In Los Angeles Dry Earwax Mystery Solved: Ear Wax Gene Identified Demountable Operating Theatre To Be Set Up At Bega Hospital More prone to SUI if symptoms appear after first pregnancy and delivery Inhaled Insulin To Be Made Available in India Lung Cancer Goes Undetected In The Early Stages

Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...

Low-profile, hand-held instrument....

Medicine Products:

Grasper, Small Joint Pointed Straight Tip, 2.75 mm, Straight Shaft Grasper, Small Joint Blunt Straight Tip, 2.75 mm, Straight Shaft Small Joint Small Joint Grasper Small Joint PITBULL™ Jr. Grasper

Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon(R) for Chronic H...( Albuferon 1200-mcg Every Two Weeks (A...),Health